AVTR101

Developed for: muscular atrophy
Investigated by: Ajou University School of Medicine · Asan Medical Center · Aventi Biotechnology Inc. · SMG-SNU Boramae Medical Center · Seoul National University Bundang Hospital

today NCT06788236 · Ph 2

2023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT06788236	May 2022 → Jun 2024	muscular atrophy	Aventi Biotechnology Inc.	Terminated	No outcome recorded Stop: Enrollment

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	AVTR101	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06788236 ↗